Features

Joy Parenting Club acquires Heba Care, widening its parenting support platform, and will roll out an AI tracker for feeding, sleep and nappies to all Joy users in 30 to 60 days. The tracker is currently in beta testing. Joy combines AI guidance on feeding, sleep, child development and everyday parenting with access to clinically [...]

By Zara Liew, director of clinical partnerships, Lindus Health Hosted by Lindus Health co-CEO Meri Beckwith, Off Protocol is the podcast that challenges the status quo of clinical trials. Each episode opens the door to honest conversations with experts across the industry — sharing real stories, confronting persistent challenges, and exploring what it takes to [...]

Bristol-based femtech firm Emm has raised US$9m in seed funding for its smart menstrual cup that tracks and analyses the menstrual cycle. Established in 2020 by Jenny Button, Emm is developing the world's first smart menstrual cup. The device combines medical-grade silicone with integrated biosensors to measure menstrual flow, cup usage and cycle patterns. Data [...]

Nearly half of countries lack national policies or clinical guidance for endometriosis care, a new global review has revealed. Endometriosis affects about one in ten women and girls worldwide. Across 194 WHO member states, researchers found striking disparities in care. More than a quarter of countries have no publicly available clinical recommendations, and only 7 [...]

By Martin Piria, senior machine learning engineer at Ema Search has changed. For years, Women's Health companies have invested in SEO, optimising their websites so Google would surface their content. But now, as consumers increasingly ask health questions directly to AI like ChatGPT, Perplexity, Ema, or Claude, a new frontier is emerging for brands that [...]

Around 5,700 breast cancer patients will now be eligible for ribociclib after NICE widened access to the combination therapy. Ribociclib will be available on the NHS for people with hormone receptor-positive, HER2-negative early breast cancer, even if their disease hasn’t spread to the lymph nodes. The drug is used with an aromatase inhibitor to help [...]

A pair of experimental drugs slowed tumour growth and blocked resistance mechanisms in ovarian cancer in a new preclinical study. Researchers found the combination selectively targeted ovarian cancer cells and reduced tumour growth in laboratory and animal models conducted ahead of human trials. Instead of focusing on individual genetic mutations, the team used a precision [...]

As founding director of Femtech Israel (IL), Shelly Bloch is working to strengthen the femtech ecosystem in Israel and beyond. Here she tells Femtech World about the trends, challenges and opportunities she sees in women’s health innovation, and her hopes for the future. “My personal passion is women,” Shelly Bloch tells Femtech World on the [...]

A new two-day summit in Hong Kong aims to highlight why supporting women’s health is not just a moral obligation but an economic imperative. Around the world, women continue to face barriers to healthcare—whether through regressive policies, underfunding or lack of access. At the same time, a growing number of women-led start-ups and companies are [...]

A groundbreaking, cross-industry initiative designed to improve adherence to clinical guidelines in the treatment of early and metastatic breast cancer has been launched by health data company Novellia. Project EVEREST unites leading researchers, clinicians, and biopharmaceutical companies - including Daiichi Sankyo, Genentech, and AstraZeneca - to identify and address the barriers preventing consistent, evidence-based cancer care across healthcare settings. [...]